Otonomy’s ear drug fails mid-stage trial, shares slide
Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière’s disease. The company’s […]
About Reuters Health
This author has yet to write their bio.Meanwhile lets just say that we are proud Reuters Health contributed a whooping 7337 entries.
Entries by Reuters Health
Memory loss may not always be first sign of Alzheimer’s
While memory loss is thought to be a classical first sign of Alzheimer’s disease, some middle-aged people and younger seniors may initially experience different cognitive problems such as trouble with […]
J&J to submit at least 10 medicines for approval by 2019
U.S. healthcare conglomerate Johnson & Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators […]
Novo Nordisk rejects Baxter patent claim over Novoeight
Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that it had infringed patents on drugs to treat the bleeding disorder hemophilia, the Danish company said […]
Four U.S. cancer charities charged; two settle
The U.S. government has charged four cancer charities with misusing more than $187 million in donations, with two agreeing to be dissolved and two fighting the allegations, the Federal Trade […]
Lpath to cut jobs as eye drug fails mid-stage study; shares fall
Drug developer Lpath Inc said it would cut jobs and costs after its experimental eye drug failed a mid-stage study in patients with wet age-related macular degeneration, a leading cause […]
Amputees control bionic legs with their thoughts
Amputees can control their bionic prosthetic limbs with their minds, thanks to tiny implanted myoelectric sensors (IMES) developed by Icelandic orthopedics company Ossur and surgically placed in a patient’s residual […]
Gilead patents on costly hepatitis C drug challenged in five countries
A U.S. group is trying to block patents in five countries for Gilead Sciences Inc’s costly hepatitis C drug Sovaldi, in a bid to give almost 60 million afflicted people […]
Most Americans still don’t use sunscreen
(Reuters Health) – Despite years of public health messages, barely one third of Americans use sunscreen regularly, according to the U.S. Centers for Disease Control and Prevention (CDC). Researchers found […]
Achillion partners with J&J to develop hepatitis C drugs
Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and […]
